Who is the manufacturer of Milbemax and what country are they from? - briefly
Milbemax is manufactured by Elanco Animal Health. This company is based in the United States.
Who is the manufacturer of Milbemax and what country are they from? - in detail
Milbemax is a well-known veterinary medication primarily used for the prevention and treatment of parasitic infections in dogs and cats. The manufacturer of Milbemax is Novartis Animal Health, a division of the global healthcare company Novartis. Novartis Animal Health is renowned for its commitment to developing innovative solutions for animal health, ensuring the well-being of pets worldwide.
Novartis Animal Health, the entity responsible for Milbemax, operates under the broader umbrella of Novartis, a Swiss multinational pharmaceutical company. Novartis is headquartered in Basel, Switzerland, a city known for its significant contributions to the pharmaceutical and chemical industries. The company's extensive research and development capabilities, coupled with its global presence, enable it to produce high-quality veterinary products that meet stringent regulatory standards.
The development and production of Milbemax reflect Novartis Animal Health's dedication to animal welfare. Milbemax contains active ingredients such as milbemycin oxime and praziquantel, which are effective against a range of parasites, including heartworms, roundworms, hookworms, tapeworms, and whipworms. This broad-spectrum efficacy makes Milbemax a popular choice among veterinarians and pet owners.
Novartis Animal Health's operations are supported by a network of research facilities, manufacturing plants, and distribution centers located in various countries. This global infrastructure ensures that Milbemax and other veterinary products are readily available to pet owners and veterinary professionals worldwide. The company's commitment to quality and innovation is evident in its adherence to Good Manufacturing Practices (GMP) and other regulatory requirements, which guarantee the safety and efficacy of its products.
In summary, Milbemax is manufactured by Novartis Animal Health, a division of the Swiss multinational company Novartis. The product's development and production are underpinned by the company's extensive research capabilities and commitment to animal health. Novartis Animal Health's global presence and adherence to regulatory standards ensure that Milbemax remains a trusted and effective solution for parasitic infections in pets.